tirzepatide shortage update FDA says this weight loss drug is over, but patients worry about cost and availability A Major GLP-1 Drug Shortage

It has FDA approval, a well-characterized safety profile, and proven efficacy for its specific target

PlexusDx's Precision Peptide Genetic Test reveals predispositions in key peptide pathway genes, including MC4R variants, which can support a more informed conversation with your provider about dose expectations

Steven T

June 2020: Ozempic Associated With Diabetic Retinopathy and Adverse Ocular Events A study found that Ozempic is associated with diabetic retinopathy and adverse ocular events more than some other GLP-1 receptor agonists

You should not take this medication if you have an allergy to atorvastatin or any of the inactive ingredients in this product